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July 13, 2010:238–42acroscopic T-Wave Alternans
he Tip of the Iceberg in
rug-Induced Torsade de Pointes?
e read with keen interest the excellent scientific statement on the
revention of torsade de pointes in hospital settings (1). The
uthors underscore the importance of averting potentially cata-
trophic events due to torsade de pointes resulting from excessive
rug-induced QT-interval prolongation. They also indicate that
hile this event is generally rare, its occurrence is more prevalent
mong hospitalized patients who have other risk factors for
rrhythmia, including underlying cardiac disease, renal or hepatic
ysfunction, and electrolyte abnormalities.
Whereas the consensus statement focuses on QT-interval pro-
ongation as a precursor of torsade de pointes, the authors draw
ttention in Figure 2 to a nefarious fellow traveler, specifically,
acroscopic T-wave alternans (TWA). Many agents, such as
miodarone, almokalant, arsenic trioxide, and pentamidine, which
nduce QT-interval prolongation, may also provoke TWA and
orsade de pointes (2). It is relevant that underlying cellular and
onic mechanisms are common to the triad of QT-interval pro-
ongation, torsade de pointes, and TWA, namely, transmural
ispersion of repolarization and excess intracellular calcium.
Because TWA reflects a continuum of electrical instability
inked to arrhythmia risk (3,4), the presence of macroscopic TWA
ay, in fact, represent the tip of the iceberg of risk associated with
roarrhythmic agents. In subjects during daily activity (5) as well as
n hospitalized patients (6), a crescendo in TWA magnitude from
onvisible to visible levels consistently occurs before the onset of
ife-threatening ventricular tachyarrhythmias. Quantification of
WA magnitude in ambulatory patients may allow even earlier
arning of impending arrhythmia on the basis of more subtle,
icrovolt levels of TWA. Prompt detection is critical because
WA is not only a marker but also a trigger of arrhythmia risk, as
t enhances repolarization heterogeneity, facilitating unidirectional
lock and re-entry. Thus, the potential utility of quantitative
WA in hospitalized patients deserves systematic study.
In the future, real-time, continuous in-hospital monitoring of
ubtle, microvolt levels of TWA could complement existing
lectrocardiography-based indicators for early warning of impend-
ng arrhythmia to avert occurrence of drug-induced torsade de
ointes.
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e applaud efforts by Drs. Verrier and Nieminen to develop novel
echnologies to detect risk for torsade de pointes (TdP) in hospital
ettings. We agree that macroscopic T-wave alternans observed
ith continuous electrocardiographic (ECG) monitoring after
dministration of QT-prolonging drugs is an important sign of
mpending TdP. However, it is not the only ECG sign to look for,
nd it is not always present before the onset of TdP. Therefore, we
mphasized the importance of looking for all the ECG signs of
mpending TdP in our summary of key points (Table 3 of our
aper [1]). We stated: following initiation of a drug associated
ith TdP, ECG signs indicative of risk for arrhythmia include an
ncrease in QTc interval from pre-drug baseline of 60 ms, marked
Tc interval prolongation 500 ms, T-U wave distortion that
ecomes more exaggerated in the beat after a pause, visible
macroscopic) T-wave alternans, new onset ventricular ectopy,
ouplets and nonsustained polymorphic ventricular tachycardia
nitiated in the beat after a pause.
Because TdP is rare and the ECG signs are subtle and not
ell-understood by monitor watchers, it would be valuable to have
etter computer algorithms built into hospital cardiac monitors to
arn for impending TdP. However, these algorithms should be
ested to determine their sensitivity and specificity for detecting
dP. Prospective clinical trials would require large sample sizes to
rovide enough episodes of TdP for such algorithm testing. A less
xpensive and immediately available research strategy would be to
se existing ECG databases. For example, the Telemetric and
olter ECG Warehouse (THEW) Center for Quantitative Elec-
rocardiography and Cardiac Safety at the University of Rochester
edical Center hosts a database of TdP cases (continuous Holter
CGs with long QT syndrome and drug-induced TdPs) that
cientists can access to validate ECG monitoring algorithms.
Computer algorithms in hospital cardiac monitors that warn of
mpending TdP might provide time to discontinue the offending
rug, administer intravenous magnesium, replace potassium (if
n
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July 13, 2010:238–42ecessary), intensify monitoring, and take measures that would
horten response time if sustained ventricular arrhythmias develop.
Barbara J. Drew
University of California, San Francisco
Koret Way
N-631H
an Francisco, California 94143-0610-mail: barbara.drew@nursing.ucsf.edu.
doi:10.1016/j.jacc.2010.04.017
EFERENCE
. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de
pointes in hospital settings: a scientific statement from the American
Heart Association and the American College of Cardiology Founda-
tion. J Am Coll Cardiol 2010;55:934–47.
